介孔硅在脑膜炎奈瑟菌转化过程中的作用：脑膜炎奈瑟菌转化过程中的环境效应。
Effect of mesoporous silica under Neisseria meningitidis transformation process: environmental effects under meningococci transformation.
机构信息
Department of Biochemistry, Institute of Biology CP6109, State University of Campinas UNICAMP, CP: 6109-CEP 13083-970, Campinas, SP, Brazil.
出版信息
J Nanobiotechnology. 2011 Jul 25;9:28. doi: 10.1186/1477-3155-9-28.
Abstract
BACKGROUND
This study aimed the use of mesoporous silica under the naturally transformable Neisseria meningitidis, an important pathogen implicated in the genetic horizontal transfer of DNA causing a escape of the principal vaccination measures worldwide by the capsular switching process. This study verified the effects of mesoporous silica under N. meningitidis transformation specifically under the capsular replacement.
METHODS
we used three different mesoporous silica particles to verify their action in N. meningitis transformation frequency.
RESULTS
we verified the increase in the capsular gene replacement of this bacterium with the three mesoporous silica nanoparticles.
CONCLUSION
the mesouporous silica particles were capable of increasing the capsule replacement frequency in N. meningitidis.
摘要
背景
本研究旨在利用在天然可转化的脑膜炎奈瑟菌中使用介孔二氧化硅，脑膜炎奈瑟菌是一种重要的病原体，其 DNA 的遗传水平转移可导致全球主要的疫苗接种措施失效，原因是荚膜转换过程。本研究验证了介孔二氧化硅在脑膜炎奈瑟菌转化，特别是在荚膜替代中的作用。
方法
我们使用了三种不同的介孔二氧化硅颗粒来验证它们在脑膜炎奈瑟菌转化频率中的作用。
结果
我们验证了这三种介孔纳米粒子增加了细菌的荚膜基因替换。
结论
介孔二氧化硅颗粒能够增加脑膜炎奈瑟菌的荚膜替换频率。
相似文献
1
Effect of mesoporous silica under Neisseria meningitidis transformation process: environmental effects under meningococci transformation.
J Nanobiotechnology. 2011 Jul 25;9:28. doi: 10.1186/1477-3155-9-28.
2
Effects of multi-walled carbon nanotubes (MWCNT) under Neisseria meningitidis transformation process.
J Nanobiotechnology. 2011 Nov 16;9:53. doi: 10.1186/1477-3155-9-53.
3
Genetic Analysis of Neisseria meningitidis Sequence Type 7 Serogroup X Originating from Serogroup A.
Infect Immun. 2017 May 23;85(6). doi: 10.1128/IAI.01019-16. Print 2017 Jun.
4
Population structure and capsular switching of invasive Neisseria meningitidis isolates in the pre-meningococcal conjugate vaccine era--United States, 2000-2005.
J Infect Dis. 2010 Apr 15;201(8):1208-24. doi: 10.1086/651505.
5
Workshop on vaccine pressure and Neisseria meningitidis, Annecy, France, 9-11 March 2005.
Vaccine. 2007 May 22;25(21):4125-9. doi: 10.1016/j.vaccine.2007.03.001. Epub 2007 Mar 19.
6
Molecular surveillance of Neisseria meningitidis capsular switching in Portugal, 2002-2006.
Epidemiol Infect. 2009 Feb;137(2):161-5. doi: 10.1017/S0950268808001106. Epub 2008 Jul 31.
7
Viability of a capsule- and lipopolysaccharide-deficient mutant of Neisseria meningitidis.
Infect Immun. 2005 Sep;73(9):6194-7. doi: 10.1128/IAI.73.9.6194-6197.2005.
8
Lung abscess due to Neisseria meningitidis serogroup X-unexpected virulence of a commensal resulting from putative serogroup B capsular switching.
Eur J Clin Microbiol Infect Dis. 2020 Dec;39(12):2327-2334. doi: 10.1007/s10096-020-03977-7. Epub 2020 Jul 14.
9
Complete genome sequence of Neisseria meningitidis serogroup B strain MC58.
Science. 2000 Mar 10;287(5459):1809-15. doi: 10.1126/science.287.5459.1809.
10
Genetic study of capsular switching between Neisseria meningitidis sequence type 7 serogroup A and C strains.
Infect Immun. 2010 Sep;78(9):3883-8. doi: 10.1128/IAI.00363-10. Epub 2010 Jul 12.
引用本文的文献
1
Vaccination with outer membrane vesicles from Neisseria Meningitidis and SBa15, SBa16 mesoporous silica associated with SARS-CoV-2 induces protective humoral and cellular response against COVID-19 in mice.
Braz J Infect Dis. 2024 Nov-Dec;28(6):104479. doi: 10.1016/j.bjid.2024.104479. Epub 2024 Nov 14.
2
Analysis of potential virulence genes and competence to transformation in Haemophilus influenzae biotype aegyptius associated with Brazilian Purpuric Fever.
Genet Mol Biol. 2020 Dec 21;44(1):e20200029. doi: 10.1590/1678-4685-GMB-2020-0029. eCollection 2020.
3
Sub lethal levels of platinum nanoparticle cures plasmid and in combination with carbapenem, curtails carbapenem resistant Escherichia coli.
Sci Rep. 2019 Mar 28;9(1):5305. doi: 10.1038/s41598-019-41489-3.
4
Analysis of the effects of mesoporous silica particles SBA-15 and SBA-16 in Streptococcus pneumoniae transformation process.
Folia Microbiol (Praha). 2019 Jan;64(1):127-132. doi: 10.1007/s12223-018-0631-2. Epub 2018 Jul 14.
5
Impact of nanoparticles on the Bacillus subtilis (3610) competence.
Sci Rep. 2018 Feb 14;8(1):2978. doi: 10.1038/s41598-018-21402-0.
6
How the Knowledge of Interactions between Meningococcus and the Human Immune System Has Been Used to Prepare Effective Neisseria meningitidis Vaccines.
J Immunol Res. 2015;2015:189153. doi: 10.1155/2015/189153. Epub 2015 Aug 17.
7
Inflammatory response of Haemophilus influenzae biotype aegyptius causing Brazilian Purpuric Fever.
Braz J Microbiol. 2015 Mar 4;45(4):1449-54. doi: 10.1590/s1517-83822014000400040. eCollection 2014.
8
Haemophilus influenzae porine ompP2 gene transfer mediated by graphene oxide nanoparticles with effects on transformation process and virulence bacterial capacity.
J Nanobiotechnology. 2014 Apr 16;12:14. doi: 10.1186/1477-3155-12-14.
9
Effects of multi-walled carbon nanotubes (MWCNT) under Neisseria meningitidis transformation process.
J Nanobiotechnology. 2011 Nov 16;9:53. doi: 10.1186/1477-3155-9-53.
本文引用的文献
1
Tuberculosis and silicosis: epidemiology, diagnosis and chemoprophylaxis.
J Bras Pneumol. 2008 Nov;34(11):959-66. doi: 10.1590/s1806-37132008001100012.
2
Study of mesoporous silica/magnetite systems in drug controlled release.
J Mater Sci Mater Med. 2009 Feb;20(2):507-12. doi: 10.1007/s10856-008-3592-1. Epub 2008 Oct 7.
3
Hyperinvasive genotypes of Neisseria meningitidis in France.
Clin Microbiol Infect. 2008 May;14(5):467-72. doi: 10.1111/j.1469-0691.2008.01955.x. Epub 2008 Feb 22.
4
Genetic and functional analyses of PptA, a phospho-form transferase targeting type IV pili in Neisseria gonorrhoeae.
J Bacteriol. 2008 Jan;190(1):387-400. doi: 10.1128/JB.00765-07. Epub 2007 Oct 19.
5
Meningococcal vaccine in travelers.
Curr Opin Infect Dis. 2007 Oct;20(5):454-60. doi: 10.1097/QCO.0b013e3282a64700.
6
The outbreak of meningitis due to Neisseria meningitidis W135 in 2003 in Burkina Faso and the national response: main lessons learnt.
Vaccine. 2007 Sep 3;25 Suppl 1:A69-71. doi: 10.1016/j.vaccine.2007.04.044. Epub 2007 May 7.
7
Molecular surveillance of meningococcal meningitis in Africa.
Vaccine. 2007 Sep 3;25 Suppl 1:A8-11. doi: 10.1016/j.vaccine.2007.04.033. Epub 2007 May 7.
8
The Neisseria meningitidis capsule is important for intracellular survival in human cells.
Infect Immun. 2007 Jul;75(7):3594-603. doi: 10.1128/IAI.01945-06. Epub 2007 Apr 30.
9
[From genomics to surveillance, prevention and control: new challenges for the African meningitis belt].
Bull Soc Pathol Exot. 2006 Dec;99(5):404-8.
10
Immunogenicity of meningococcal PBP2 during natural infection and protective activity of anti-PBP2 antibodies against meningococcal bacteraemia in mice.
J Antimicrob Chemother. 2006 May;57(5):924-30. doi: 10.1093/jac/dkl066. Epub 2006 Mar 2.
Zotero 插件